HB2634 amends the Illinois Preventing Youth Vaping Act to tighten and clarify rules governing electronic cigarettes sold in the state. The bill keeps in place the general prohibition on selling, distributing, importing, or possessing for sale e-cigarettes that are improperly packaged, intended for foreign markets, or otherwise noncompliant with federal warning and trademark requirements. It also preserves the existing rule that certain e-cigarettes requiring federal premarket review are adulterated unless they have the required FDA authorization, while creating a specific exception for products first sold before August 8, 2016, that had a pending premarket tobacco product application submitted to the FDA by September 9, 2020.
The bill adds a new certification requirement for distributors, secondary distributors, and retailers. Before selling or distributing e-cigarettes in Illinois, they would have to obtain and keep a manufacturer certification stating the products are not adulterated, including information about the FDA application submission date or marketing order date. Sellers would be prohibited from handling products without that certification, but they would not be liable for false or misleading statements made by the manufacturer in the certification. The bill also authorizes enforcement of these certification provisions by the Attorney General under the Consumer Fraud and Deceptive Business Practices Act, in addition to existing enforcement by the Department of Revenue.
HB2634 would affect Illinois tobacco-control and tax enforcement law by modifying Sections 15 and 35 of the Preventing Youth Vaping Act and adding a new Section 15a. It would expand compliance obligations for the e-cigarette supply chain, create a recordkeeping duty for retailers and distributors, and reinforce seizure, forfeiture, license suspension, and civil penalty remedies for violations. The bill also narrows potential exposure for downstream sellers by shifting responsibility for certification accuracy to manufacturers.
Overall sentiment appears to be supportive of stronger regulatory oversight of vaping products, consistent with the bill’s youth-vaping prevention title, but the available record does not include committee debate or votes. Based on the text, the measure seems designed to balance enforcement against illicit or noncompliant products with protections for legitimate products that are in the FDA review pipeline. The main point of potential contention is likely the treatment of pre-2016 products with pending FDA applications, along with the added compliance burden on distributors and retailers and the expanded enforcement role for the Attorney General.
HB2634 would amend the Preventing Youth Vaping Act by revising the definition of adulterated electronic cigarettes, creating a manufacturer certification regime for distributors, secondary distributors, and retailers, and adding Attorney General enforcement under the Consumer Fraud and Deceptive Business Practices Act. It would increase documentation, retention, and production requirements for sellers, while preserving existing Department of Revenue penalties, license actions, and contraband seizure provisions for violations.
No committee transcript or vote history is available, so there is no recorded debate to gauge member sentiment. From the bill text and caption, the measure appears to be framed as a youth-vaping enforcement bill with a generally regulatory, public-health-oriented purpose. The structure suggests support for tighter oversight of e-cigarette sales while also accommodating products that are in the federal FDA review process.
The most likely point of contention is the bill’s exception for electronic cigarettes first sold before August 8, 2016, that had a pending FDA premarket tobacco product application submitted by September 9, 2020, because that carveout may be viewed as either a necessary accommodation for legacy products or an overly broad exemption. Another possible issue is the new compliance burden on distributors, secondary distributors, and retailers, who must obtain and retain manufacturer certifications and may face enforcement if they sell uncertified products. The bill also shifts responsibility for false certification statements to manufacturers and limits downstream liability, which could be debated by regulators and industry stakeholders.